Option News Today — November 10, 2026
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound and more — today's option signal.
US markets are bracing for potential volatility as investors digest a mixed bag of news. On the economic front, hot inflation continues to be a concern, with rising consumer prices likely to keep the Federal Reserve on track for a rate hike. This backdrop is set to influence trading in major tech stocks, including Nvidia, which saw a massive trade go off recently. Meanwhile, Asian tech stocks, including SoftBank Group, rallied sharply today following a rebound on Wall Street, highlighting the interconnectedness of global markets.
Beyond the market movements, several companies are making headlines. The FDA has issued a warning about a potential risk of vision loss associated with popular GLP-1 drugs such as Wegovy and Zepbound. In other news, Securitize, a tokenization platform, saw its shares rise 10% postmarket after announcing its Q3 results and a move into asset-backed finance. These developments, along with ongoing political debates, are set to shape market sentiment and trading activity in the coming days, making it crucial for investors to stay informed and consider their strategies carefully.
Today's signal:
• FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound (cnbc.com)
• SoftBank Group shares surge 11% as Asian tech stocks rally after Wall Street rebounds (cnbc.com)
• Tokenization platform Securitize gains 10% postmarket on Q3 results, move into asset-backed finance (cnbc.com)
• A massive trade in Nvidia just went off – here are the details (cnbc.com)
• Hot U.S. inflation hasn’t cooled off. Rising consumer prices to keep Fed rate hike on track. (marketwatch.com)
• Trump questions midterm election results, revives voting-machine conspiracy (cnbc.com)